Millennium Pharmacon International Tbk. vs Saraswanti Indoland Development Tbk. — how do they compare? Millennium Pharmacon International Tbk. trades at Rp179 (market cap 230.59B, 19.2K 24h volume), while Saraswanti Indoland Development Tbk. trades at Rp92 (market cap 490.04B, 1.51M 24h volume). The key difference: Saraswanti Indoland Development Tbk. is far larger — about 2.1× Millennium Pharmacon International Tbk.'s market cap, and Saraswanti Indoland Development Tbk. is more actively traded (1.51M versus 19.2K). Which is the better fit depends on your goals.
| SDPC | SWID | |
|---|---|---|
Market Cap | 230.59B | 490.04B |
Volume | 19.2K | 1.51M |
Lot | 192 | 15.14K |
Turnover | 3.43M | 137.63M |
Average Price | 178.62 | 90.94 |
Value | 3.43M | 137.63M |
Indicative Equilibrium Price | — | 92 |
Indicative Equilibrium Volume | — | 1.49K |
Trailing returns across standard periods
Latest headlines on both assets
PT Millennium Pharmacon International Tbk (the Company) was established on October 20th, 1952 under the name N.V. Perusahaan Dagang SOEDARPO CORPORATION. On July 29th, 1997, the Extraordinary Shareholders meeting held by the Company has approved the sale of assets and of the whole share participation on the Company in PT Praweda Ciptakarsa Informatika and PT Sumber Daya Praweda Informatika. In order to strengthen its equity and settle the foreign currently loan, the Company has conducted its first Right Issue and has submitted the registration statement on May 8th, 2000 to the Capital Advisory Board (BAPEPAM). The Company started its operations on October 20, 1952. The name was changed from previous name PT NVPD Soedarpo Corporation.
Read more on SDPC →PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.
Read more on SWID →